EXAGEN INC. cotiza a 8.48 USD y tiene una capitalización bursátil de $205M. En los últimos 12 meses ha facturado $71M con un margen de flujo de caja libre del -21.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases, including systemic l…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.11 | $-0.20 | $-0.27 |
| Estimado | $-0.17 | $-0.17 | $-0.25 | $-0.19 |
| Sorpresa | — | +35.3% | +20.0% | -42.1% |
| Métrica | XGN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 58.3% | 57.0% | +1.2% |
| Operating Margin | -21.1% | -38.6% | +17.5% |
| Net Margin | -30.0% | -33.6% | +3.6% |
| FCF Margin | -21.4% | -13.9% | -7.6% |
| ROE | -114.3% | -40.4% | -73.9% |
| ROA | -34.4% | -32.0% | -2.4% |
| Current Ratio | 3.45 | 2.84 | +0.61 |
| Debt / Equity | 1.31 | 0.28 | +1.03 |